Witold Pomiecko

发表

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial.

E. Kerwin, E. Bleecker, D. Bernstein, 2017, The Lancet. Respiratory medicine.